Recent Headlines
Colorado BioScience Association Commends Governor Ritter for Supporting Creation of New Bioscience Companies and Fostering Retention of 400+ Existing Firms
The Colorado BioScience Association (CBSA) commends Governor Ritter for crafting an economic development agenda for 2008 that will spur the creation of new bioscience companies and help the state retain the 400 plus companies that exist today. The restructuring of the corporate income tax to a system based on in-state sales will make Colorado competitive with others states that understand the value of high-paying technology-based jobs. - September 27, 2007 - Colorado BioScience Association
Best-Selling Author Jim Collins Headlines Stellar Lineup of National Presenters for the 2007 BioWest Conference and Expo, Now Open for Registration
Registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2007. More than 900 participants are expected at this year’s event, December 6-7, at the Grand Hyatt in Denver. Best-selling author & noted management scholar Jim Collins headlines a stellar lineup of national presenters for BioWest 2007. - September 21, 2007 - Colorado BioScience Association
DNA Solutions Appoint Middle East Agent
EBT, a company based in Dubai, UAE, has acquired the rights to distribute DNA Solution's DNA portfolio of DNA testing services. Offering a range of services including DNA relationship analysis, databanking, preservation & ancestry. EBT will provide the ability to rapidly and accurately offer a resolve to any biological issue - September 21, 2007 - DNA Solutions
Russian and Indian CROs Announce Network Alliance for Expansion of Global Clinical Trials Services
On September 12, 2007 Synergy Research Group (SynRG), a Russia-based CRO with more than 5-years experience in clinical trials in Russia announced the establishment of a new CRO Worldwide Network alliance with Neeman Medical International (NMI), an India-based CRO. This is the second step made by... - September 14, 2007 - Synergy Research Group
BioWest 2007 Organizers Seek the Best and Brightest of the Rocky Mountain Region’s Bioscience Start-Ups for the Venture Showcase Competition
BioWest, The Rocky Mountain Region’s Premier Bioscience Conference and Expo, is again looking for the best bioscience start-ups in the region as candidates for the $10,000 Faegre & Benson Venture Showcase Award. Six companies will be chosen to present at the Showcase in December, which will be judged by a panel of national venture capitalists. Deadline for entry is September 28, 2007. - August 30, 2007 - Colorado BioScience Association
November Conference Will Show Healthcare Providers How to Partner with Corporations to Provide Wellness Programs
The goal of this conference is to introduce healthcare providers to the $5.8 billion corporate wellness market, show them how to develop and prepare for corporate wellness partnerships and to give insight into the corporation’s needs and goals for providing clinically sound and impactive wellness programs. - August 25, 2007 - Immuno Laboratories
Synergy Research Group and Promedica International Announce Global Network Alliance for Expansion of Global Clinical Trials Services
On August 2, 2007 Synergy Research Group (SynRG), a Russia based CRO with more than 5-years experience in clinical trials in Russia announced today the establishment of a new Global Network Alliance with Promedica International (PMI), a USA-based CRO. Promedica International (PMI), which... - August 04, 2007 - Synergy Research Group
CoreRx™ Celebrates Its First Year of Operations
CoreRx™ celebrates its first year of operations 01 August2007. In their initial year of business CoreRx™ has serviced more than 25 clients, both domestic and abroad. The company has positioned themselves for successful growth strategies over the next few years. Included in... - August 03, 2007 - CoreRx, Inc.
Clinical Trials in Russia - 2nd Quarter 2007
On July 25, 2007 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. The report contains hundreds of figures as well as 11 Tables and 9 Pictures covering various aspects of the... - July 27, 2007 - Synergy Research Group
Local Merger Creates Advanced Orthopedics and Sports Medicine Institute
Western Monmouth Orthopedic Associates and New Jersey Orthopedic Associates have merged to form Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI). The seven practicing physicians have a combined 100 years of experience practicing medicine, and are all committed to providing Patient-Centered, Patient-Focused care, positioning AOSMI as a leading provider of orthopedic health care in Central New Jersey and the Monmouth County, NJ area. - July 23, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
Dr. Nasar Appointed Medical Director of CentraState Total Joint Center
Dr. Alan Nasar, a leading orthopedic surgeon at the Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI), is the newly appointed medical director of the Total Joint Center of New Jersey. He draws from his training and experience in orthopedic care and mechanical engineering to offer his patients a variety of joint replacement options that are designed for faster recovery and better outcomes. - July 11, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
Advanced Orthopedics and Sports Medicine Institute Revolutionizes Knee Replacement Procedures for Women
The orthopedic surgeons at the Advanced Orthopedics and Sports Medicine Institute, PC (AOSMI) are among the first surgeons in the Freehold, New Jersey area to offer the Zimmer® Gender Solutions™ Knee, which is the first and only knee replacement shaped to fit a woman’s anatomy. - July 11, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
Clinical Trials in Russia. 1st Quarter 2007 Results
According to Synergy Research Group, a Russia-based CRO, the growth in the number of clinical trials approved by the Russian Federal Agency for Health Care and Social Development (Roszdravnadzor) made up to nearly 40% in the 1st Quarter of 2007 as compared to the same quarter of the previous year. At the same time, the share of clinical studies initiated by Russian manufacturers has increased. - June 06, 2007 - Synergy Research Group
The Imminent Change of the Antithrombotics Market
The antithrombotics market with the two blockbusters enoxaparin and prasugrel is challenged by generic products as well as by next generation anticoagulants with oral administration and antithrombotics with an improved risk-benefit ratio - June 01, 2007 - La Merie Business Intelligence
Colorado BioScience Association Applauds Governor Ritter’s Signing of HB 1060 As Critical To Future Growth of The State’s Bioscience Industry
Colorado Governor Bill Ritter signed House Bill 1060 into law Wednesday afternoon, with the bill sponsors present to acknowledge the importance of the legislation to the bioscience industry in Colorado. Rep. Jim Riesberg (D-Weld) and Sen. Brandon Shaffer (D-Longmont) were thanked for their efforts... - May 25, 2007 - Colorado BioScience Association
Colorado BioScience Association Names Jack Wheeler Chairperson, Announces 2007 Sponsors and Appoints Eight New Board Members
Jack Wheeler, CEO of MicroPhage, Inc., Longmont, is the new chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2007 annual meeting April 24th. Wheeler assumes chairperson responsibilities from Ed Wood, ArcScan, Inc. In other action, eight new board members were appointed to three-year terms. - May 18, 2007 - Colorado BioScience Association
Clinical Trials in Russia - First Issue of SynRG Orange Paper
On April 25, 2007, the first issue of the Orange Paper – the first analytical review on market of clinical trials in Russia – was officially presented. The strategic goals of Synergy Research Group, a Russia-based emerging CRO, are formation of a civilized market of clinical trials in... - May 16, 2007 - Synergy Research Group
CoreRx, Inc. Announces New Expanded Capabilities
CoreRx, Inc. is an American owned company located in Tampa, Florida. CoreRx, Inc. announces the expansion of it’s capabilities including DEA licensure for controlled substances. This gives CoreRx, Inc. the ability to work with DEA schedule 2-5 active pharmaceutical ingredients and drug... - May 12, 2007 - CoreRx, Inc.
2007-08 Bioscience Colorado Magazine Debuts at BIO International Convention in Boston
Colorado Bioscience Association is releasing the new edition of Bioscience Colorado Magazine at the 2007 BIO International Convention, May 6-9, at the Boston Convention & Exhibition Center. This year’s magazine has expanded to 80 pages and includes an updated directory of the Colorado Bioscience industry: Medical Device and Related Companies; Biotechnology, Pharmaceutical and Related Companies; Biofuels and Related Companies; Research & Education Institutions; Foundations; & Service Providers. - May 06, 2007 - Colorado BioScience Association
New Technology to Study the Mechanism of Cancer
Switchgear Genomics unveils new experimental technology to characterize the biological networks of cancer cells. - April 12, 2007 - SwitchGear Genomics
RTC Introduces a New Line
RTC Introduces a New Line of Secondary/Working Pharmaceutical Reference Standards to Meet the Needs of Labs Working in an ISO 17025 Environment - April 04, 2007 - RTC
Colorado Bioscience Association Launches Colorado Springs Chapter
The debut of the Colorado Springs Chapter of the Colorado Bioscience Association (CBSA) occurred yesterday at the University of Colorado at Colorado Springs (UCCS). The announcement is made by Denise Brown, CBSA Executive Director, who says UCCS Chancellor Pam Shockley hosted the chapter launch event. - March 29, 2007 - Colorado BioScience Association
Transcutaneous Bioelectric Stimulation - the Problem of Penetration and Propagation
In the past few years, there has been a resurgence of interest in bio-electrical therapies in the medical community. In some areas however, there has been a proliferation of research resulting in numerous clinical applications directed at patient care. Many health care facilities are successfully... - March 17, 2007 - Technical AP
Two Leading Biotech Publications Report on Advaxis’ Listeria Platform Technology
Advaxis’ John Rothman Recognized as one of 20 Notable People in R&D - March 16, 2007 - Advaxis
Two Colorado Bioscience Legislative Initiatives Rank Among BIO’s Best Practices in the Nation
Two Colorado bioscience legislative initiatives are included in the national BIO “State Legislative Best Practices in Support of Bioscience Industry Development,” report issued late last year for state legislation promoting growth of bioscience clusters in 2005-06. Of the 23 standout initiatives, only two other states, California and Texas, had two projects highlighted. - March 14, 2007 - Colorado BioScience Association
UK Paternity Testing Centre Unveils New Online Resource
DNA Diagnostics Centre (DDC), a leading international DNA testing laboratory, recently launched its website in the UK, www.dnacentre.co.uk. The website serves as a useful resource for clients in the UK and Europe who require DNA testing services, such as paternity testing for immigration or child support. - March 08, 2007 - DNA Diagnostics Center
The New Class of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Has One Clear Leader and Many Followers
Merck & Co clearly leads the field of DPP-IV inhibitors which has many followers in clinical development. The first companies already abandoned the field. - March 05, 2007 - La Merie Business Intelligence
Four Colorado Companies Participate at the 2007 Rocky Mountain Bioscience Venture Capital Meeting on the Mountain in Park City, Utah
Four Colorado-based companies are participating at the 2007 Rocky Mountain Bioscience Venture Capital Meeting on the Mountain, March 2-4, at the Park City (UT) Marriott. Dorsey & Whitney, lead sponsor of the event, hosts venture capitalists and area companies to learn and explore bioscience opportunities in the Rocky Mountain Region. Co-sponsors include UV Partners, vSpring Capital and Wasatch Venture Fund. - March 04, 2007 - Colorado BioScience Association
Creating New Life Forms that May Help Eradicate Cancer Affecting Women
Instead of using the usual cancer-fighting modalities, surgery, chemotherapy, or radiation, researchers from a drug development company called Advaxis, have embarked on a novel approach to fighting cancer: Engaging the immune system to attack cancer in the same the way it would a flu vaccine, by... - February 27, 2007 - Advaxis
TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln
Sales of the major cancer antibodies grew by 57 % to US$ 10.6 bln in 2006. Cancer antibodies are challenging the still No. 1 selling class of erythropoietins with 2006 sales of US$ 11.9 bln, but the lowest growth rate (6.4%), and got ahead of TNF antibodies which posted sales of 10.3 bln (+ 25%). - February 27, 2007 - La Merie Business Intelligence
Discount Blood Tests via the Internet
Stat Health Screens, LLC, announced today that, beginning immediately, they will broker Discounted Blood Tests to consumers throughout the U.S. - via the internet. Millions of consumers who use google.com to search for medical information can now locate discounted blood tests within a few... - February 26, 2007 - econoLABS
Colorado Bioscience Association Showcases the State’s Most Promising Technologies
Colorado research institutions have begun reaping the rewards of legislation allocating state funds for bioscience research. HB 1360, sponsored by Representative Jim Reisberg (D-Greeley) and Senator Ron Tupa (D-Boulder), was signed into law by Governor Bill Owens last summer. $2 million in state funds was awarded to 27 bioscience proof of concept projects at six Colorado universities and research institutions. Initial reports are expected by the end of 2007. - February 23, 2007 - Colorado BioScience Association
Carrington Laboratories and Racing Legend Johnny Rutherford Sign Endorsement and Personal Agreement
Carrington Laboratories, Inc. (Nasdaq: CARN) announced it has entered into a one-year endorsement and personal services agreement with racing legend Johnny Rutherford. The partnership provides a platform for Carrington to reach the rapidly growing and attractive racing enthusiast consumer... - February 17, 2007 - Carrington Laboratories
Twenty-Four Colorado Companies Exhibited at the West Coast's Largest Design and Manufacturing Show, MD&M West
Twenty-four Colorado-based companies exhibited at the 23rd annual Medical Device & Manufacturing (MD&M) West show in Anaheim, CA, February 13-15. Colorado has a strong medical device manufacturing sector and was well represented at the MD&M trade show and conference. Several of Colorado’s regional economic development agencies were also in Anaheim assisting exhibiting companies and promoting the State of Colorado as a great place for doing business. - February 16, 2007 - Colorado BioScience Association
HiTIS - Life Science & Biotech Intelligence, A Global Life Sciences Industry Focused Competitive Intelligence Firm, Launched Skin Diseases Drug Development Weekly
HiTIS - life science & biotech intelligence, a global life sciences industry focused competitive intelligence firm, launched Skin Diseases Drug Development Weekly while the American Academy of Dermatology held its 65th annual meeting. - February 12, 2007 - HiTIS - Life Science & Biotech Intelligence
Dosing Convenience is Mandatory to Keep Pace in the Pipeline Race of GLP-1 Analogs for Type 2 Diabetes
The Business Intelligence firm La Merie S.L. reported today that major diabetes companies are trying to keep pace with Eli Lilly and Amylin Pharmaceutical in the field of GLP-1 analogs to treat type 2 diabetes. Lilly’s and Amylin’s first-in-class, but twice-daily product exenatide... - February 06, 2007 - La Merie Business Intelligence
Overview on 2006 Sales of Top 20 Biologics to Be Released on February 26
A free compilation of the 2006 sales of the TOP 20 blockbuster and other major recombinant antibodies and proteins will be provided by La Merie Business Intelligence starting February 26. - February 05, 2007 - La Merie Business Intelligence
NeuroscienceCME.com Launches New Sleep and Wake Medicine Clinical Knowledge Center
Web-based resource for sleep professionals offers education, guidelines, references, etc. - January 24, 2007 - CME Outfitters, LLC
Diluted Insulin Injections for Type 1 Diabetes Sufferers Are Now Available at Teregen Labs
Pharmacists at Teregen Labs can prepare diluted insulin in response to the growing need not met through retail pharmacies. When a Diluted Insulin Injection is needed, often when a patient is on an insulin pump, things typically get worse for diabetes sufferers. Teregen Labs regularly dilutes Insulin for diabetes sufferers with a valid prescription from their physician faxed into their pharmacy for an affordable price. - January 16, 2007 - Teregen Labs
The Right Balance Drives the Field of PPAR Agonist R&D
A strongly growing market of now more than US$ 6 billion in 2006 for only two PPAR gamma agonists founds the basis for a heavily researched field of next generation mono, dual or triple PPAR agonists with fine-tuned subtype combinations. - January 12, 2007 - La Merie Business Intelligence
Cincinnati Children's Named One of Top Five Children's Hospitals in Child Magazine's Top Children's Hospitals Survey
Cincinnati Children's Hospital Medical Center is among the five best children's hospitals in the United States overall, and among the top five in the nation for pediatric cancer care and neonatal care, according to Child magazine's prestigious Ten Best Children's Hospital survey. Child magazine... - January 05, 2007 - Cincinnati Children's Hospital Medical Center
Weekly Monitor Drug and Diagnostic Development in Neurodegenerative Diseases
HiTIS - life science & biotech intelligence, a European life sciences industry focused competitive intelligence firm, recently launched Neurodegenerative Diseases Therapeutics & Diagnostics Competitive Intelligence Weekly - November 30, 2006 - HiTIS - Life Science & Biotech Intelligence
HiTIS - Life Science & Biotech Intelligence Expands Web Presence with www.txpreview.com
HiTIS - life science & biotech intelligence, a European life sciences industry- focused competitive intelligence firm, has released its corporate website. - November 23, 2006 - HiTIS - Life Science & Biotech Intelligence
Put an Eye on the Weekly Electronic Publication Covering Drug and Device-Based Available Treatments, Current Research and Upcoming Therapies Addressing Eye Disorders
HiTIS - life science & biotech intelligence, a life sciences industry focused competitive intelligence firm, has released the 26th weekly issue of its Eye Care industry competitive intelligence publication: Eye Therapies Competitive Intelligence Weekly (ETCI Weekly). - November 20, 2006 - HiTIS - Life Science & Biotech Intelligence
Reputed Orthopaedic Surgeon to Join Business Intelligence Services Firm HiTIS Team as Scientific and Medical Advisor
Life science industry-focused competitive intelligence services practice adds outstanding orthopaedics expertise to founding team to develop new competitive intelligence periodical reports. - October 17, 2006 - HiTIS - Life Science & Biotech Intelligence
Delivery Improvements of the AMD-drug Lucentis on the Way
The anti-VEGF Fab Lucentis is the new standard of care to treat AMD because it can improve visual acuity. Competitor drugs directed against the same and innovative targets are applied with non-intravitreal forms of administration to avoid the unease of intra-vitreal injection. - September 20, 2006 - La Merie Business Intelligence
InViragen Announces Exclusive Patent License Agreement with the Centers for Disease Control
InViragen, LLC, a biotechnology company dedicated to developing vaccines for emerging infectious diseases worldwide, has entered into an Exclusive Patent License Agreement with the Centers for Disease Control and Prevention (CDC). The licensed technology is applicable to vaccines against multiple viral diseases, including dengue fever and West Nile disease. Dengue fever threatens 2.5 billion people worldwide as well as travelers to tropical countries. - September 14, 2006 - Colorado BioScience Association
Biologics Define New Standard of Therapy in Psoriasis
Anti-TNF agents set the new gold standard of psoriasis treatment which could be outperformed by smarter next generation biologics and small molecules in safety and convenience. - September 08, 2006 - La Merie Business Intelligence
Leading Colorado Biotechnology and Medical Device Companies Selected to Present at BIO Mid-America VentureForum
Five Colorado-based companies have been selected to present at the Biotechnology Industry Organization (BIO) Mid-America VentureForum to be held September 25-27th at the InterContinental Hotel in Cleveland, Ohio. These companies are among more then 50 companies selected by venture capitalists from the nation’s leading firms who serve on BIO’s advisory board. - September 07, 2006 - Colorado BioScience Association
ApopLogic Pharmaceuticals Wins the Second Annual Faegre & Benson Venture Showcase Award, Presented at BioWest 2006
ApopLogic Pharmaceuticals has won the second annual Faegre & Benson Venture Showcase Award at the BioWest 2006 conference in Denver. The announcement is made by Chris Shapard, bioscience director at the Colorado Office of Economic Development and International Trade (OEDIT), who says the $10,000 Venture Showcase Award was again provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards banquet held Thurs. evening at the Colo. Convention Center. - August 25, 2006 - Colorado BioScience Association